In vitro antileishmanial activity and phytochemical analysis of Carissa edulis against Leishmania major
Abstract
Background: However, there is need to carry out scientific studies in order to confirm the medicinal properties of many plants used traditionally. Carissa edulis Forskk. (Gentiales: Apocynaceae) used by local communities for the treatment of various diseases has showed antiviral, antibacterial and antiprotozoal properties although there are no studies demonstrating its antileishmanial activity.
Objective: To investigate in vitro antileishmanial activity of extracts of Carissa edulis on promastigote and amastigote forms of Leishmania major.
Methodology: Solvent extraction of the stem parts of C. edulis was performed using water, methanol, petroleum ether, dichloromethane and ethyl acetate. Minimum inhibitory concentration (MIC), anti-amastigote and nitric oxide production assays were carried out to demonstrate antileishmanial activity of C. edulis extracts against the two forms of L. major parasite species: promastigote and amastigote. The extracts were also screened for phytochemical constituents present. Cytotoxicity assay was then done to assess their safe use as herbal medicinal products.
Results: The C. edulis petroleum ether extract showed the strongest antileishmanial activity against L. major promastigotes (MIC=625μg/ml) with the water, dichloromethane and ethyl acetate extracts recording the weakest activity (MIC=2500μg/ml). The successive methanol extract reduced the number L. major amastigotes by 88.29% compared to the negative control (RPMI). The water (13.37μM), petroleum ether (12.93μM) and successive methanol extracts (12.82μM) produced nitrite values lower than the standard drugs Pentostam® (14.35μM) and Amphotericin B (14.13μM).
Discussion: All C. edulis extracts have potential antileishmanial activity against L. major. Preliminary phytochemical screening of these extracts showed presence of alkaloids, terpenoids, phenols, anthraquinones and saponins. These phytochemicals were previously reported to have antileishmanial activity. Therefore, the plant extracts could offer an opportunity to develop cheaper antileishmanial alternatives to the more expensive pentavalent antimonials.
Key words: C. edulis, L. major, promastigote, amastigoteReferences
Alvar J, Iván D, Caryn B, Mercé H, Philippe D, Jorge C, Jean J, and de Boer M (2012). Leishmaniasis Worldwide and Global Estimates of Its Incidence. Martyn Kirk (Ed). PLoS ONE 7: e35671.
Assmar M, Farahmand M, Aghigi Z and Ghaemi N (2003). In vitro and in vivo evaluation of therapeutic effects of Vinca major alkaloids on Leishmania major. Journal of School of Public Health & Institute of Public Health Researches. 1:1-8.
Ateş DA, and Özlem TE (2003). Antimicrobial Activities of Various Medicinal and Commercial Plant Extracts. Turk. J. Biol. 27:157–162.
Augusto O, Linares E and Giorgio S (1996). Possible roles of nitric oxide and peroxynitrite in murine leishmaniasis. Braz. J. Med. Biol. Res. 29: 853-862.
Beach R, Kiilu G, Hendricks LD, Oster CN and Leeuwenburg J (1984). Cutaneous leishmaniasis in Kenya: transmission of Leishmania major to man by the bite of a naturally infected Phlebotomus duboscqi. Trans. R. Soc. Trop. Med. Hyg. 78: 747-751.
Berman JD and Lee LS (1984). Activity of antileishmanial agents against amastigotes in human monocyte derived macrophages and in mouse peritoneal macrophages. J. Parasitol. 70: 220-225.
Berridge MV, Herst PM, Tan AS (2005). Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu, Rev. 11: 127-152.
Bodiwala HS, Singh G, Singh R, Dey CS, Sharma SS, Bhutani KK and Singh IP (2007). Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum. J. Nat. Med. 61: 418-421.
Boelaert M and Sundar S (2013). Leishmaniasis. In Manson’s Tropical Diseases, edited by Farrar J, Hotez P, Junghansi T, Kang G, Lalloo D, and White N, 23rd ed., 631–51e4. Saunders.
Chan-Bacab MJ and Pena-Rodriguez LM (2001). Plant natural products with leishmanicidal activity. Nat. Prod. Rep. 18: 674–688.
Chen M, Christensen SB, Theander TG and Kharazmil A (1994). Antileishmanial activity of Licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob. Agents Chemother. 38: 1339-1344.
Croft SL and Coombs GH (2003). Leishmaniasis - Current Chemotherapy and Recent Advances in the Search for Novel Drugs. Trends Parasitol. 19: 502–508.
Croft SL, Sundar S and Fairlamb AH (2006). Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev. 19: 111–126.
David J, Soares M, Satoskar A, Brombacher F, Shoemaker C, Titus R and Bozza M (1997). Immunomodulatory properties of maxadilan, a peptide derived from sand fly saliva. Turk. J. Parasitol. 21 (Suppl.1): 174.
Delmas F, Di Giorgio C, Elias R, Gasquet M, Azas N, Mshvildadze V, Dekanosidze G, Kemertelidze E and Timon DP (2000). Antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside action on mammalian cells cultured in vitro. Planta Medica 66: 343-347.
Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Da Cuhna Pinto A, Henriques AT, Bou-Habib DC and Saraiva EM (2001). Anti-leishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob. Agents Chemother. 45: 1349-1354.
Desjeux P (2004). Leishmaniasis: Current Situation and New Perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27: 305–318.
Donald JA (Ed) (2003). Burger medicinal chemistry and drug discovery. 6th ed. Vol. 5. John Wiley and Sons, Inc., Virginia: 1347-1352.
Dorin D, Le Roch K, Sallicandro P, Alano P, Parzy D, Poullet L, Meijer L and Doerig C (2001). Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum. Biochemical properties and possible involvement in MAPK regulation. Eur. J. Biochem. 268: 2600-2608.
Dube A, Nasib S, Shyam S and Neeloo S (2005). Refractoriness to the Treatment of Sodium Stibogluconate in Indian Kala-Azar Field Isolates Persist in in Vitro and in Vivo Experimental Models. Parasitol. Res. 96: 216–223.
Dulger B, Ugurlu E, Aki C, Suerdem TB, Camdeviren A and Tazeler G (2005). Evaluation of Antimicrobial Activity of Some Endemic Verbascum, Sideritis, and Stachys Species from Turkey. Pharm. Biol. 43: 270–274.
Dutta A, Goutam M, Chitra M and Mitali C (2007). In Vitro Antileishmanial Activity of Aloe Vera Leaf Exudate: A Potential Herbal Therapy in Leishmaniasis. Glycoconj. J. 24 (1): 81–86.
Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urba M and Sarek J (2006). Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep. 23: 394-411.
Ellis G, Adatia I, Yazdanpanah M and Makela SK (1998). Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin. Biochem. 31: 195-220.
Evans D, Godfrey D, Lanham S, Lanotte G, Modabber F and Schnurl I (1989). In: Evans, D. (Ed.), Handbook on Isolation Characterization and Cryopreservation of Leishmania. UNDP/World Bank/WHO/TDR, Geneva.
Ferreira ME, Arias AR, Ortiz ST, Inchausti A, Nakayama H, Thouvenel C, Hocquemiller R and Fournet A (2002). Leishmanicidal activity of two canthin-6-one alkaloids, two major constituents of Zanthoxylum chiloperone var. angustifolium. J. Ethnopharmacol. 80: 199-202.
Fournet A, Barrios AA, Munoz V, Hocquemiller R, Cave A and Bruneton J (1993). 2-substituted quinoline alkaloids as potential antileishmanial drugs. Antimicrob. Agents Chemother. 37: 859-863.
Fournet A, Barrios AA, Munoz V, Hocquemiller R, Roblot F, Cave AL, Richomme P and Bruneton J (1994). Antiprotozoal activity of quinoline alkaloids isolated from Galìpea longijlora, a Bolivian plant used as a treatment for cutaneous leishmaniasis. Phytother. Res. 8:174-178.
Fournet A, Ferreira ME, De Arias AR, De Ortiz ST, Fuentes S, Nakayama H, Schinini A and Hocquemiller R (1996). In vivo efficacy of oral and intralesional administration of 2- substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob. Agents Chemother. 40: 2447-2451.
Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK and Bryceson ADM (2002). Visceral Leishmaniasis: Current Status of Control, Diagnosis, and Treatment, and a Proposed Research and Development Agenda. Lancet Infect. Dis. 2 (8): 494–501.
Harbone JB (1994). Biochemistry of Phenolic Compounds. Academic Press. London.
Harborne, A. J. (1998). Phytochemical methods a guide to modern techniques of plant analysis. Springer Science & Business Media.
Harborne JB (1998). Phytochemical Methods. J. B. Harborne ed. chapman and hall London. In, Nonita, P.P., Mylene, M. U., (2010). Antioxidant and cytotoxic activities and phytochemical screening of four philipine medicinal plant. J. Med. Plants Res. 4: 407-414.
Hendricks LD and Wright N (1979). Diagnosis of Cutaneous Leishmaniasis by in vitro cultivation of saline aspirates in Schneider’s Drosophila medium. Am. J. Trop. Med. Hyg. 28: 962-964.
Henriques AT, Bou-habib DC and Saraiva EMB (2001). Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob. Agents Chemother. 45: 1349–1354.
Hollzmuller P, Sereno D, Calvalrero M, Mangot L, Dauloude S, Vincendeau P and Lemesre JL (2002). Nitric oxide-mediated proteasome-development oligonucleosomal DNA fragmentation in L. amazonensis amastigotes. Infect. Immun. 70: 3727-3735.
Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD and Savioli L (2007). Control of Neglected Tropical Diseases. New Eng. J. Med. 357 (10): 1018–1027.
James SL (1995). Role of nitric oxide in parasitic infections. Microbiol. Rev. 59: 533 – 547.
Kavoosi G, Ardestani SK, Kariminia A and Tavakoli Z (2006). Production of nitric oxide by murine Macrophages induced by lipophosphoglycan of Leishmania major. Korean J. Parasitol. 44: 35-41.
Kimber CD, Evans DA, Robinson BL and Peters W (1981). Control of yeast contamination with 5-fluorocytosine in in vitro cultivation of Leishmania spp. Ann. Trop. Med. Parasitol. 75: 453-454.
Kingondu EVM, Rukunga GM, Keriko JM, Tonui WK, Gathitwa JW, Kirira PG, Irungu B, Ingonga JM and Ndiege IO (2009). Anti-parasitic activity and cytotoxicity of selected medicinal plants from Kenya. J. Ethnopharmacol. 123: 504-509.
Koide T, Mitsuhiko N, Yuiko O, Yoshisada Y and Nobuo O (2002). Leishmanicidal effect of curcumin in vitro. Biol. Pharm. Bull. 25: 131-133.
Kumar VP, Chauhan NS, Padh H and Rajani M (2006). Search for Antibacterial and Antifungal Agents from Selected Indian Medicinal Plants. J. Ethnopharmacol. 107: 182–188.
Leiw FY, Wei XQ and Proudfoot L (1997). Cytokines and nitric oxide as effector molecules against parasitic infections. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 352: 1311-1315.
Louis J, Himmelrich H, Parra-Lopez C, Tacchini-Cottier F and Launois P (1998). Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10: 459-464.
MacMicking J, Xie QW and Nathan C (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350.
Maes L, Berghe DV, Germonprez N, Quirijnen L, Cos P, De Kimpe N and Puyvelde LV (2004a). In vitro and in vivo activities of a triterpenoid saponin extract (PX- 6518) from the plant Maesa balansae against visceral leishmania species. Antimicrob. Agents Chemother. 48: 130-136.
Maes L, Germonprez N, Quirijnen L, Puyvelde LV, Cos P and Berghe DV (2004b). Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against eishmania donovani in hamsters. Antimicrob. Agents Chemother. 48: 2056-2060.
Mathabe MC, Nikolova RV, Lall N and Nyazema NZ (2006). Antibacterial Activities of Medicinal Plants Used for the Treatment of Diarrhoea in Limpopo Province, South Africa. J. Ethnopharmacol. 105: 286–293.
Mendonça-Filho RR, Rodrigues IA, Alviano DS, Santos ALS, Soares RMA, Alviano CS, Lopes AH and Rosa MS (2004). Leishmanicidal activity of polyphenolic-rich extract from husk fiber of Cocos nucifera Linn (Palmae). Res. Microbiol. 155: 136-143.
Mori K, Kawano M, Fuchino H, Ooi T, Satake M, Agatsuma Y, Kusumi T and Sekita S (2007). Antileishmanial compounds from Cordia fragrantissima collected in Burma. J. Nat. Prod. 71: 18 - 21.
Mosser DM (2003). The many faces of macrophage activation. J. Leukoc. Biol. 73: 209-212.
Nair R, Kalariye T and Chanda S (2005). Antimicrobial Activity of some selected Indian medicinal Flora. Turk. J. Biol. 29: 41-47.
Ogungbe VI and Setzer WN (2013). In-silico Leishmania target Selectivity of antiparasitic terpenoids. Molecules 18: 7761-7847.
Oliver RA, Foo Y, Yinrong LU, Albrecht KF and Herbert K (2003). Evaluation of sage phenolics for their antileishmanial activity and modulatory effects on interleukin-6, interferon and tumour necrosis factor-a-release in RAW 264.7 cells. J. Biosci. 58: 395-400.
Tan N, Kaloga M, Radtke OA, Kiderlen AF, Oksuz S, Ulubelen A and Kolodziej H (2002). Abietane diterpenoids and triterpenoic acids from Salvia cilicica and their antileishmanial activities. Phytochemistry. 61: 881-884.
Teixeira MCA, Santos JR and Sampaio RB (2002). A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species. Parasitol. Res. 88: 963-968.
Tonthubthimthong P, Chuaprasert S, Douglas P and Luewisutthichat W (2001). Supercritical CO 2 extraction of nimbin from neem seeds–an experimental study. J. Food Eng. 47: 289-293.
Tonui WK, Santiago JM, Hochberg L, Chan AST, Mbow LM, Ryan JR, Martin SK and Titus RG (2004). Immunization with Leishmania major secreted/excreted (exo) antigens protects susceptible mice against challenge infection with L. major. Infect. Immun. 72: 5654-5661.
Şengül M, Öğütcü H, Adıgüzel A, Şahin F, Kara AA, Karaman I and Güllüce M (2005). Antimicrobial effects of Verbascum georgicum Bentham extract. Turk. J. Biol. 29: 105-110.
Singh S (2006). New Developments in Diagnosis of Leishmaniasis. Indian J. Med. Res. 123: 311–330.
Sofowora AE (1993). Medicinal Plants and Traditional Medicine in Africa. 2nd ed. Ibadan, Nigeria: Spectrum Books.
Sternberg J, Mabbott N, Sutherland I and Liew FY (1994). Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection. Infect. Immun. 62: 2135-2137.
Wang X, Ge JM, Wang K, Qian J and Zou Y (2006). Emodin-induced cytotoxicity. Assay Drug Dev. Technol. 4: 203-207.
World Health Organization (2010). Control of the Leishmaniases. World Health Organization Technical Report Series, no. 949: xii – xiii, 1–186, back cover.
Full Text: PDF
Refbacks
- There are currently no refbacks.